Neogen (NEOG) Income from Continuing Operations (2010 - 2026)
Neogen (NEOG) posted quarterly Income from Continuing Operations of 10500000.0 for Q2 2026, up 97.47% year-over-year from 5317201.02 in Q2 2025, and up 38.24% quarter-over-quarter from 17000000.0 in Q1 2026.
Neogen (NEOG) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 10500000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 97.47% year-over-year to 10500000.0; the TTM figure through May 2026 stood at 7086000.0 (up 99.21% YoY), while the FY2026 annual figure was 7100000.0, up 99.21% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 10500000.0, up from 17000000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 36338000.0 in Q3 2025, with the low at 456282000.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 4440500.0 (2023), against an average of 51177611.11.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations slumped 12985.23% in 2024, then soared 388.19% in 2025.
- Neogen's Income from Continuing Operations stood at 41841000.0 in 2022, then jumped by 91.67% to 3487000.0 in 2023, then plunged by 12985.23% to 456282000.0 in 2024, then surged by 96.51% to 15924000.0 in 2025, then jumped by 34.06% to 10500000.0 in 2026.
- Business Quant data shows NEOG's Income from Continuing Operations at 10500000.0 in Q2 2026, 17000000.0 in Q1 2026, and 15924000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -10.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -10.50 Mn |
| Feb 28, 2026 | -17.00 Mn |
| Nov 30, 2025 | -15.92 Mn |
| Aug 31, 2025 | 36.34 Mn |
| May 31, 2025 | -651.44 Mn |
| Feb 28, 2025 | -10.90 Mn |
| Nov 30, 2024 | -456.28 Mn |
| Aug 31, 2024 | -12.61 Mn |
| May 31, 2024 | -5.42 Mn |
| Feb 29, 2024 | -2.02 Mn |
| Nov 30, 2023 | -3.49 Mn |
| Aug 31, 2023 | 1.50 Mn |
| May 31, 2023 | 6.38 Mn |
| Feb 28, 2023 | 8.19 Mn |
| Nov 30, 2022 | -41.84 Mn |
| Aug 31, 2022 | 5.21 Mn |
| May 31, 2022 | 14.22 Mn |
| Feb 28, 2022 | 5.44 Mn |
| Nov 30, 2021 | 10.83 Mn |
| Aug 31, 2021 | 17.08 Mn |